Newsfeeds - Spark Newswire

4 minute read

EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In February — Including Tesla, Apple And A Surging AI Name

Today, 10:00 PM

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.

AAPL

4 minute read

Collaboration With Kiora Pharmaceuticals And The Royal Adelaide Hospital, Leading Australian CRO, Accelagen Clinical Trial Underway To Improve Vision In Individuals With Advanced Retinitis Pigmentosa

By Happy Mohamed

Today, 10:00 PM

Putting Australian clinical research on the map globally, comes the ground-breaking first-in-human clinical trial for KIO-301. MELBOURNE, Australia, Feb. 14, 2023 /PRNewswire/ -- In collaboration with US-based

KPRX

1 minute read

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target

By Benzinga Newsdesk

Today, 10:00 PM

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $10 price target.

KPRX

1 minute read

Ladenburg Thalmann Reiterates Buy on Kiora Pharmaceuticals, Maintains $119 Price Target

By Benzinga Newsdesk

Today, 10:00 PM

Ladenburg Thalmann analyst Matthew Kaplan reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $119 price target.

KPRX

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 10:00 PM

Gainers Lixte Biotech Hldgs (NASDAQ:LIXT) shares rose 97.3% to $1.6 during Tuesday’s regular session. Trading volume for this…

CDIO

18 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 10:00 PM

Thursday's session saw 329 companies set new 52-week lows.

ABNB

2 minute read

Peering Into Kiora Pharmaceuticals’s Recent Short Interest

By Benzinga Insights

Today, 10:00 PM

Kiora Pharmaceuticals's (NASDAQ:KPRX) short percent of float has fallen 51.07% since its last report. The company recently reported that it has 28 thousand shares sold short, which is 2.52% of all regular shares that are available for trading.

KPRX

2 minute read

Peering Into Kiora Pharmaceuticals’s Recent Short Interest

By Benzinga Insights

Today, 10:00 PM

Kiora Pharmaceuticals's (NASDAQ:KPRX) short percent of float has fallen 19.5% since its last report. The company recently reported that it has 84 thousand shares sold short, which is 7.43% of all regular shares that are available for trading.

KPRX

3 minute read

Nasdaq Down 0.5%; Clearfield Shares Spike Higher

By Lisa Levin

Today, 10:00 PM

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping over 50 points on Friday.

CLFD

4 minute read

Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 10:00 PM

Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.

AMBA